COVID-19
University of Miami Leads a Pilot Program to Track Variants of COVID-19
Feb. 26 2021 | Share
nanoparticles
COVID-19
Sylvester Researcher Finds FDA-Approved Antiviral Drug Can Be Delivered Via Nanoparticle for COVID-19
A Sylvester Comprehensive Cancer Center researcher at the University of Miami Miller School of Medicine has found that an orally administered nanoparticle can deliver the FDA-approved drug Ivermectin to suppress the COVID-19 virus. “Our…
Cancer Research
Flexible Nanoparticle System Could Deliver Oral Drugs Safely Through Gut Into the Bloodstream
Researchers have struggled with the challenge of getting oral medications past the treacherous environment of the gut intact and into the bloodstream where they can be most effective. But now…